Nutraceuticals in Acute and Prophylactic Treatment of Migraine

Headache disorders are third cause of disability worldwide

(2015) Timothy J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Migrende Tamamlayıcı ve Alternatif Tedavi Yöntemlerinin Kullanımı

(2013) Başak Karakurum GÖKSEL   Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Long-term efficacy of Boswellia serrata in four patients with chronic cluster headache

(2012) Christian Lampl et al.   CEPHALALGIA

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]

(2012) S. Holland et al.   NEUROLOGY

Boswellia serrata

(2011) Mona Abdel-Tawab et al.   CLINICAL PHARMACOKINETICS

Migraine prophylactic drugs – something new under the sun?

(2011) Svein I Bekkelund et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Alternative Headache Treatments: Nutraceuticals, Behavioral and Physical Treatments

(2011) Christina Sun-Edelstein et al.   HEADACHE

Migraine prevalence by age and sex in the United States: A life-span study

(2010) TW Victor et al.   CEPHALALGIA

Large Conductance Calcium-Activated Potassium Channels (BKCa) Modulate Trigeminovascular Nociceptive Transmission

(2009) RJ Storer et al.   CEPHALALGIA

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs

(2009) C. Di Lorenzo et al.   NEUROLOGY

The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability

(2009) Rod Lea et al.   Pharmacogenetics and Genomics

Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment

(2008) M. E. Bigal et al.   NEUROLOGY